ENOV
Overvalued by 115% based on the discounted cash flow analysis.
Market cap | $2.87 Billion |
---|---|
Enterprise Value | $4.15 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-1.5 |
Beta | 1.16 |
Outstanding Shares | 54,850,906 |
Avg 30 Day Volume | 639,840 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -35.1 |
---|---|
PEG | -16.85 |
Price to Sales | 1.59 |
Price to Book Ratio | 0.87 |
Enterprise Value to Revenue | 2.28 |
Enterprise Value to EBIT | -86.14 |
Enterprise Value to Net Income | -51 |
Total Debt to Enterprise | 0.32 |
Debt to Equity | 0.4 |
No data
No data
Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax...